Arformoterol * recalls

The FDA has published 2 recalls involving Arformoterol * since 2021. The latest was reported on 12 Oct 2022. Most were for sterility. Cipla has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2021

Last 12 months0reported

Class I00% of total

Ongoing0latest 12 Oct 2022

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why arformoterol * is recalled

Sterility2100%

Companies

Cipla150%
Glenmark Pharmaceuticals Inc., USA150%

By year

2022150%
2021150%

All arformoterol * recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
12 Oct 2022Drug	CLASS II	Arformoterol Tartrate Inhalation Solution, 15 mcg/ Sterile Unit-Dose recalledArformoterol Tartrate	Cipla	Sterility	Nationwide
29 Sep 2021Drug	CLASS II	Arformoterol Tartrate Inhalation Solution 15 mcg*/ For Oral recalled	Glenmark Pharmaceuticals Inc., USA	Sterility	Nationwide

Should you stop taking Arformoterol *?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.